ArticleScience translational medicine2019

ZEB1 suppression sensitizes KRAS mutant cancers to MEK inhibition by an IL17RD-dependent mechanism.

David H Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.